Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adultsShow others and affiliations
2021 (English)In: BMC Geriatrics, E-ISSN 1471-2318, Vol. 21, no 1, p. 1-12, article id 600Article in journal (Refereed) Published
Abstract [en]
Background The operational definition of sarcopenia has been updated (EWGSOP2) and apply different cut-off points compared to previous criteria (EWGSOP1). Therefore, we aim to compare the sarcopenia prevalence and the association with mortality and dependence in activities of daily living using the 2010 (EWGSOP1 and 2019 (EWGSOP2 operational definition, applying cut-offs at two levels using T-scores.
Methods Two birth cohorts, 70 and 85-years-old (n = 884 and n = 157, respectively), were assessed cross-sectionally (57% women). Low grip strength, low muscle mass and slow gait speed were defined below − 2.0 and − 2.5 SD from a young reference population (T-score). Muscle mass was defined as appendicular lean soft tissue index by DXA. The EWGSOP1 and EWGSOP2 were applied and compared with McNemar tests and Cohen’s kappa. All-cause mortality was analyzed with the Cox-proportional hazard model.
Results Sarcopenia prevalence was 1.4–7.8% in 70-year-olds and 42–62% in 85 years-old’s, depending on diagnostic criteria. Overall, the prevalence of sarcopenia was 0.9–1.0 percentage points lower using the EWGSOP2 compared to EWGSOP1 when applying uniform T-score cut-offs (P < 0.005). The prevalence was doubled (15.0 vs. 7.5%) using the − 2.0 vs. -2.5 T-scores with EWGSOP2 in the whole sample. The increase in prevalence when changing the cut-offs was 5.7% (P < 0.001) in the 70-year-olds and 17.8% (P < 0.001) in the 85-year-olds (EWGSP2). Sarcopenia with cut-offs at − 2.5 T-score was associated with increased mortality (hazard ratio 2.4–2.8, P < 0.05) but not at T-score − 2.0.
Conclusions The prevalence of sarcopenia was higher in 85-year-olds compared to 70-year-olds. Overall, the differences between the EWGSOP1 and EWGSOP2 classifications are small. Meaningful differences between EWGSOP1 and 2 in the 85-year-olds could not be ruled out. Prevalence was more dependent on cut-offs than on the operational definition.
Place, publisher, year, edition, pages
2021. Vol. 21, no 1, p. 1-12, article id 600
Keywords [en]
Diagnostic criteria, Sarcopenia, Mortality, EWGSOP, Muscle mass, Gait speed, Handgrip strength, Population sample, Ageing, Activities of daily living, H70
National Category
Geriatrics
Identifiers
URN: urn:nbn:se:hkr:diva-22651DOI: 10.1186/s12877-021-02533-yISI: 00711415800003PubMedID: 34702174OAI: oai:DiVA.org:hkr-22651DiVA, id: diva2:1608507
Funder
Swedish Research Council, 2012-5041Swedish Research Council, 2015-02830Swedish Research Council, 2019-01096Swedish Research Council, 2013-8717Swedish Research Council, 2017-00639Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-1202Forte, Swedish Research Council for Health, Working Life and Welfare, 2018-00471Forte, Swedish Research Council for Health, Working Life and Welfare, AGECAP 2013-2300Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-2496Konung Gustaf V:s och Drottning Victorias FrimurarestiftelseThe Swedish Brain Foundation, FO2014-0207The Swedish Brain Foundation, FO2016-0214The Swedish Brain Foundation, FO2018-0214The Swedish Brain Foundation, FO2019-0163The Swedish Brain Foundation, FO2020-0235Alzheimerfonden, AF-554461Alzheimerfonden, AF-647651Alzheimerfonden, AF-743701Alzheimerfonden, AF-844671Alzheimerfonden, AF-930868Alzheimerfonden, AF-940139Eivind och Elsa K:son Sylvans stiftelseSwedish Research Council, 2007-7462Swedish Research Council, 2012-5041Swedish Research Council, 2015-02830Swedish Research Council, 2019-01096Swedish Research Council, 2013-8717Swedish Research Council, 2017-00639Forte, Swedish Research Council for Health, Working Life and Welfare, 2006-0596Forte, Swedish Research Council for Health, Working Life and Welfare, 2008-1111Forte, Swedish Research Council for Health, Working Life and Welfare, 2010-0870Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-1202Forte, Swedish Research Council for Health, Working Life and Welfare, AGECAP 2013-2300Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-2496Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-0475Konung Gustaf V:s och Drottning Victorias FrimurarestiftelseThe Swedish Brain Foundation, FO2014-0207The Swedish Brain Foundation, FO2016-0214The Swedish Brain Foundation, FO2018-0214The Swedish Brain Foundation, FO2019-0163The Swedish Brain Foundation, FO2020-0235Alzheimerfonden, AF-554461Alzheimerfonden, AF-647651Alzheimerfonden, AF-743701Alzheimerfonden, AF-844671Alzheimerfonden, AF-930868Alzheimerfonden, AF-940139Eivind och Elsa K:son Sylvans stiftelse
Note
The 1944 study on 70-year-olds was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF 716681) [...]
The 1930 study on 85-year-olds was fnanced by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF 716681, 722441) [...] The Alzheimer’s Association Zenith Award (ZEN-01-3151), The Alzheimer’s Association (IIRG-09-131338). Open access funding provided by University of Gothenburg.
2021-11-032021-11-032024-07-04Bibliographically approved